TNPO2

Chr 19

transportin 2

Also known as: IDDHISD, IPO3, KPNB2B, TRN2

Predicted to enable nuclear import signal receptor activity and nuclear localization sequence binding activity. Predicted to be involved in protein import into nucleus. Predicted to act upstream of or within negative regulation of muscle cell differentiation. Predicted to be active in cytoplasm and nucleus. Implicated in intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies. [provided by Alliance of Genome Resources, Jul 2025]

ResearchGenerating clinical summary…
LOFmechanismLOEUF 0.13
Clinical SummaryTNPO2
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
17 unique Pathogenic / Likely Pathogenic· 84 VUS of 171 total submissions
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.13LOEUF
pLI 1.000
Z-score 6.20
OE 0.04 (0.020.13)
Highly constrained

Among the most LoF-intolerant genes (~top 3%)

Missense Constraint?
5.88Z-score
OE missense 0.28 (0.250.33)
152 obs / 534.3 exp
Constrained

Extremely missense-constrained (top ~0.01%)

Observed / Expected Ratios?
LoF OE?0.04 (0.020.13)
00.351.4
Missense OE?0.28 (0.250.33)
00.61.4
Synonymous OE?1.01
01.21.6
LoF obs/exp: 2 / 48.6Missense obs/exp: 152 / 534.3Syn Z: -0.15
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedTNPO2-related intellectual disabilityOTHERAD

This gene — mechanism propensity

DN
0.3395th %ile
GOF
0.3689th %ile
LOF
0.68top 10%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · 1 literature citation · LOEUF 0.13

Literature Evidence

LOFStudies of another variant (W727C) suggested a loss-of-function effect.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 34314705

ClinVar Variant Classifications

171 submitted variants in ClinVar

Classification Summary

Pathogenic4
Likely Pathogenic13
VUS84
Likely Benign30
Benign8
Conflicting2
4
Pathogenic
13
Likely Pathogenic
84
VUS
30
Likely Benign
8
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
4
0
0
4
Likely Pathogenic
2
11
0
0
13
VUS
6
71
7
0
84
Likely Benign
0
6
7
17
30
Benign
0
1
3
4
8
Conflicting
2
Total8931721141

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

19 pathogenic / likely-pathogenic (of 28) ClinVar copy-number / structural variants overlap TNPO2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

TNPO2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →